NAV
$41.06
AUM
$3.5B
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.81
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +10.23% | +2.11% | +5.26% | +22.56% | +19.26% | +10.25% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ASML.AS | ASML Holding NV | 2.35% |
| 2 | NOVN.SW | Novartis AG Registered Shares | 2.09% |
| 3 | ABBN.SW | ABB Ltd | 1.15% |
| 4 | RY | Royal Bank of Canada | 1.14% |
| 5 | ROP.SW | Roche Holding AG Ordinary Shares new | 1.05% |
| 6 | HSBA.L | HSBC Holdings PLC | 1.02% |
| 7 | BHP.AX | BHP Group Ltd | 1.01% |
| 8 | NESN.SW | Nestle SA | 0.98% |
| 9 | AZN.L | AstraZeneca PLC | 0.92% |
| 10 | 8306.T | Mitsubishi UFJ Financial Group Inc | 0.89% |
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index is composed of large- and mid-capitalization equity securities from the STOXX Global 1800 ex USA index (the “parent index”) that are selected and weighted using an optimization process designed to maximize exposure to five target factors: momentum, quality, value, low volatility and size.
Inception Date: 2015-04-28